Case 227: Endobronchial Carcinoid Tumor with Incidental Metastatic Breast Cancer Detected with Somatostatin Receptor Scintigraphy ((111)In Pentreotide).

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Radiology

• Publication date

  2016-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/radiol.2016141475PMID 26885736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis

  2014cited by this paper
• Somatostatin receptor-based PET/CT of intracranial tumors: a potential area of application for 68 Ga-DOTA peptides?

  2013cited by this paper
• Positron emission tomography/computed tomography in locally advanced breast cancer.

  2013cited by this paper
• Spectrum of pulmonary neuroendocrine proliferations and neoplasms.

  2013cited by this paper
• Imaging features of carcinoid tumors metastatic to the breast

  2011cited by this paper
• NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

  2009cited by this paper
• Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.

  2009cited by this paper
• Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors

  2008cited by this paper
• Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.

  2008cited by this paper
• Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma

  2008cited by this paper
• Carcinoid tumors.

  2008cited by this paper
• Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours

  2008cited by this paper
• TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

  2007cited by this paper
• Anatomic and functional imaging of metastatic carcinoid tumors.

  2007cited by this paper
• The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours.

  2006cited by this paper
• The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours

  2006cited by this paper
• Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.

  2006cited by this paper
• Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours

  2004cited by this paper
• Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

  2004cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67

  2002cited by this paper
• Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings.

  2002cited by this paper
• Somatostatin receptor scintigraphy useful in stage I–II Hodgkin's disease: more extended disease identified

  2001cited by this paper
• Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography

  2000cited by this paper
• Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties.

  1999cited by this paper
• Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

  1999cited by this paper
• Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.

  1998cited by this paper
• 111Indium Pentetreotide Scan Detection of Familial Paragangliomas

  1998cited by this paper
• Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen.

  1998cited by this paper
• Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography

  1997cited by this paper
• Dynamic indium-111-pentetreotide scintigraphy in breast cancer.

  1996cited by this paper
• Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies.

  1996cited by this paper
• Breast cancer

  1995cited by this paper
• Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.

  1995cited by this paper
• Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.

  1995cited by this paper
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

  1993cited by this paper
• Mucoid impaction of a bronchus.

  1978cited by this paper

• The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals

  2020cites this paper